These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37356652)

  • 1. Effect of Doxycycline on Progression of Arterial Calcification in the Noninvasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT).
    Kim TI; Kostiuk V; Olson SL; Curci JA; Matsumura JS; Baxter BT; Blackwelder WC; Terrin ML; Guzman RJ
    Ann Vasc Surg; 2024 Jul; 104():1-9. PubMed ID: 37356652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair.
    Hackmann AE; Rubin BG; Sanchez LA; Geraghty PA; Thompson RW; Curci JA
    J Vasc Surg; 2008 Sep; 48(3):519-26; discussion 526. PubMed ID: 18632241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.
    Baxter BT; Pearce WH; Waltke EA; Littooy FN; Hallett JW; Kent KC; Upchurch GR; Chaikof EL; Mills JL; Fleckten B; Longo GM; Lee JK; Thompson RW
    J Vasc Surg; 2002 Jul; 36(1):1-12. PubMed ID: 12096249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm.
    Baxter BT; Matsumura J; Curci J; McBride R; Blackwelder WC; Liu X; Larson L; Terrin ML;
    Contemp Clin Trials; 2016 May; 48():91-8. PubMed ID: 27018941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial.
    Baxter BT; Matsumura J; Curci JA; McBride R; Larson L; Blackwelder W; Lam D; Wijesinha M; Terrin M;
    JAMA; 2020 May; 323(20):2029-2038. PubMed ID: 32453369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial.
    Meijer CA; Stijnen T; Wasser MN; Hamming JF; van Bockel JH; Lindeman JH;
    Ann Intern Med; 2013 Dec; 159(12):815-23. PubMed ID: 24490266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
    Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
    J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
    Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
    J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment.
    Sangiorgi G; D'Averio R; Mauriello A; Bondio M; Pontillo M; Castelvecchio S; Trimarchi S; Tolva V; Nano G; Rampoldi V; Spagnoli LG; Inglese L
    Circulation; 2001 Sep; 104(12 Suppl 1):I288-95. PubMed ID: 11568071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline.
    Ding R; McGuinness CL; Burnand KG; Sullivan E; Smith A
    Vascular; 2005; 13(5):290-7. PubMed ID: 16288704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results.
    Georgiadis GS; Antoniou GA; Argyriou C; Schoretsanitis N; Nikolopoulos E; Kapoulas K; Lazarides MK; Tentes I
    J Endovasc Ther; 2019 Dec; 26(6):826-835. PubMed ID: 31464166
    [No Abstract]   [Full Text] [Related]  

  • 13. Low Iliofemoral Calcium Score May Predict Higher Survival after EVAR and FEVAR.
    Vaccarino R; Abdulrasak M; Resch T; Edsfeldt A; Sonesson B; Dias NV
    Ann Vasc Surg; 2020 Oct; 68():283-291. PubMed ID: 32339675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
    Lorelli DR; Jean-Claude JM; Fox CJ; Clyne J; Cambria RA; Seabrook GR; Towne JB
    J Vasc Surg; 2002 May; 35(5):916-22. PubMed ID: 12021707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
    Nosoudi N; Nahar-Gohad P; Sinha A; Chowdhury A; Gerard P; Carsten CG; Gray BH; Vyavahare NR
    Circ Res; 2015 Nov; 117(11):e80-9. PubMed ID: 26443597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
    Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
    Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW
    J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater aortic inflammation and calcification in abdominal aortic aneurysmal disease than atherosclerosis: a prospective matched cohort study.
    Joshi NV; Elkhawad M; Forsythe RO; McBride OMB; Rajani NK; Tarkin JM; Chowdhury MM; Donoghue E; Robson JMJ; Boyle JR; Fryer TD; Huang Y; Teng Z; Dweck MR; Tawakol AA; Gillard JH; Coughlin PA; Wilkinson IB; Newby DE; Rudd JHF
    Open Heart; 2020; 7(1):e001141. PubMed ID: 32201583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
    Lindeman JH; Abdul-Hussien H; van Bockel JH; Wolterbeek R; Kleemann R
    Circulation; 2009 Apr; 119(16):2209-16. PubMed ID: 19364980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.